[1]
|
Saeedi, P., Petersohn, I., Salpea, P., et al. (2019) Global and Regional Diabetes Prevalence Estimates for 2019 and Pro-jections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th Edition. Diabetes Re-search and Clinical Practice, 157, Article ID: 107843. https://doi.org/10.1016/j.diabres.2019.107843
|
[2]
|
中华医学会肾脏病学分会专家组. 糖尿病肾脏疾病临床诊疗中国指南[J]. 中华肾脏病杂志, 2021, 37(3): 255-304.
|
[3]
|
De Boer, I.H., Caramori, M.L., Chan, J.C.N., et al. (2020) KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney International, 98, S1-S115. https://doi.org/10.1016/j.kint.2020.06.019
|
[4]
|
Gonzalez-Perez, A., Saez, M., Vizcaya, D., et al. (2021) Incidence and Risk Factors for Mortality and End-Stage Renal Disease in People with Type 2 Diabetes and Diabetic Kidney Dis-ease: A Population-Based Cohort Study in the UK. BMJ Open Diabetes Research and Care, 9, e002146. https://doi.org/10.1136/bmjdrc-2021-002146
|
[5]
|
国家老年医学中心, 中华医学会老年医学分会, 中国老年保健协会糖尿病专业委员会. 中国老年糖尿病诊疗指南(2021年版) [J]. 中华糖尿病杂志, 2021, 13(1): 14-46.
|
[6]
|
Russo, G.T., De Cosmo, S., Viazzi, F., et al. (2018) Diabetic Kidney Disease in the Elderly: Prevalence and Clinical Correlates. BMC Geriatrics, 18, Article No. 38. https://doi.org/10.1186/s12877-018-0732-4
|
[7]
|
Roy, S., Schweiker-Kahn, O., Jafry, B., et al. (2021) Risk Factors and Comorbidities Associated with Diabetic Kidney Disease. Journal of Primary Care & Community Health, 12, Article ID: 21501327211048556.
https://doi.org/10.1177/21501327211048556
|
[8]
|
Jiang, W., Wang, J., Shen, X., et al. (2020) Establishment and Validation of a Risk Prediction Model for Early Diabetic Kidney Disease Based on a Systematic Review and Me-ta-Analysis of 20 Cohorts. Diabetes Care, 43, 925-933.
https://doi.org/10.2337/dc19-1897
|
[9]
|
Farah, R.I., Al-Sabbagh, M.Q., Momani, M.S., et al. (2021) Diabetic Kid-ney Disease in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study. BMC Nephrology, 22, Article No. 223.
https://doi.org/10.1186/s12882-021-02429-4
|
[10]
|
Wang, J., Han, Q., Zhao, L., et al. (2019) Identification of Clini-cal Predictors of Diabetic Nephropathy and Non-Diabetic Renal Disease in Chinese Patients with Type 2 Diabetes, with Reference to Disease Course and Outcome. Acta Diabetologica, 56, 939-946. https://doi.org/10.1007/s00592-019-01324-7
|
[11]
|
Adler, A.I., Stevens, R.J., Manley, S.E., et al. (2003) Develop-ment and Progression of Nephropathy in Type 2 Diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney International, 63, 225-232.
https://doi.org/10.1046/j.1523-1755.2003.00712.x
|
[12]
|
De Boer, I.H., Afkarian, M., Rue, T.C., et al. (2014) Renal Outcomes in Patients with Type 1 Diabetes and Macroalbuminuria. Journal of the American Society of Nephrology, 25, 2342-2350. https://doi.org/10.1681/ASN.2013091004
|
[13]
|
Yu, M.K., Lyles, C.R., Bent-Shaw, L.A., et al. (2012) Risk Factor, Age and Sex Differences in Chronic Kidney Disease Prevalence in a Diabetic Cohort: The Pathways Study. American Journal of Nephrology, 36, 245-251.
https://doi.org/10.1159/000342210
|
[14]
|
Valdivielso, J.M., Jacobs-Cacha, C. and Soler, M.J. (2019) Sex Hormones and Their Influence on Chronic Kidney Disease. Current Opinion in Nephrology and Hypertension, 28, 1-9. https://doi.org/10.1097/MNH.0000000000000463
|
[15]
|
Giandalia, A., Giuffrida, A.E., Gembillo, G., et al. (2021) Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical Factors. International Journal of Molecular Sciences, 22, Article No. 5808.
https://doi.org/10.3390/ijms22115808
|
[16]
|
Inada, A., Inada, O., Fujii, N.L., et al. (2016) Adjusting the 17β-Estradiol-to-Androgen Ratio Ameliorates Diabetic Nephropathy. Journal of the American Society of Nephrology, 27, 3035-3050.
https://doi.org/10.1681/ASN.2015070741
|
[17]
|
Ibrahim, M.M. (2010) Subcutaneous and Visceral Adipose Tissue: Structural and Functional Differences. Obesity Reviews, 11, 11-18. https://doi.org/10.1111/j.1467-789X.2009.00623.x
|
[18]
|
华艳龙, 张林. 内脏脂肪面积在糖尿病肾病危险因素筛查中的应用价值[J]. 中国基层医药, 2020, 27(5): 605-607.
|
[19]
|
Khanam, P.A., Hoque, S., Begum, T., et al. (2017) Microvascular Complications and Their Associated Risk Factors in Type 2 Diabetes Mellitus. Diabetes Diabetes & Met-abolic Syndrome, 11, S577-S581.
https://doi.org/10.1016/j.dsx.2017.04.007
|
[20]
|
Wang, Y., Zhao, L., Zhang, J., et al. (2019) Implications of a Family History of Diabetes and Rapid EGFR Decline in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Kidney Dis-ease. Frontiers in Endocrinology, 10, Article No. 855. https://doi.org/10.3389/fendo.2019.00855
|
[21]
|
Wang, Y., Zhang, J., Zhao, Y., et al. (2018) COL4A3 Gene Variants and Diabetic Kidney Disease in Mody. Clinical Journal of the American Society of Nephrology, 13, 1162-1171. https://doi.org/10.2215/CJN.09100817
|
[22]
|
Doke, T., Huang, S., Qiu, C., et al. (2021) Transcriptome-Wide Association Analysis Identifies DACH1 as a Kidney Disease Risk Gene That Contributes to Fibrosis. Journal of Clinical Investigation, 131, e141801.
https://doi.org/10.1172/JCI141801
|
[23]
|
Zhang, L., He, S., Guo, S., et al. (2014) Down-Regulation of Mir-34a Al-leviates Mesangial Proliferation in Vitro and Glomerular Hypertrophy in Early Diabetic Nephropathy Mice by Targeting Gas1. Journal of Diabetes and Its Complications, 28, 259-264. https://doi.org/10.1016/j.jdiacomp.2014.01.002
|
[24]
|
梁田田, 王惠珍, 柒春芳, 等. 糖尿病和糖尿病肾病小鼠肾组织中长链非编码RNA的差异表达[J]. 中华肾脏病杂志, 2019, 35(2): 127-135.
|
[25]
|
Tommerdahl, K.L., Shapiro, A.L.B., Nehus, E.J., et al. (2022) Early Microvascular Complications in Type 1 and Type 2 Diabetes: Recent Developments and Updates. Pediatric Nephrology, 37, 79-93.
https://doi.org/10.1007/s00467-021-05050-7
|
[26]
|
Deng, L., Aibibula, W., Talat, Z., et al. (2021) The Association between Glycaemic Control during Hospitalization and Risk of Adverse Events: A Retrospective Cohort Study. Endo-crinology, Diabetes & Metabolism, 4, e00268.
https://doi.org/10.1002/edm2.268
|
[27]
|
Stratton, I.M., Cull, C.A., Adler, A.I., et al. (2006) Additive Effects of Gly-caemia and Blood Pressure Exposure on Risk of Complications in Type 2 Diabetes: A Prospective Observational Study (UKPDS 75). Diabetologia, 49, 1761-1769. https://doi.org/10.1007/s00125-006-0297-1
|
[28]
|
Fullerton, B., Jeitler, K., Seitz, M., et al. (2014) Intensive Glucose Control versus Conventional Glucose Control for Type 1 Diabetes Mellitus. Cochrane Database of Systematic Reviews, No. 2, Article No: CD009122.
https://doi.org/10.1002/14651858.CD009122.pub2
|
[29]
|
Shurraw, S., Hemmelgarn, B., Lin, M., et al. (2011) As-sociation between Glycemic Control and Adverse Outcomes in People with Diabetes Mellitus and Chronic Kidney Dis-ease: A Population-Based Cohort Study. Archives of Internal Medicine, 171, 1920-1927. https://doi.org/10.1001/archinternmed.2011.537
|
[30]
|
Patel, D.M., Bose, M. and Cooper, M.E. (2020) Glucose and Blood Pressure-Dependent Pathways—The Progression of Diabetic Kidney Disease. International Journal of Molecular Sciences, 21, 2218. https://doi.org/10.3390/ijms21062218
|
[31]
|
陈雪, 周倩倩, 徐慧君, 等. 不同血压变量及其变异性对2型糖尿病肾病的影响[J]. 中华内分泌代谢杂志, 2021, 37(7): 624-630.
|
[32]
|
Beddhu, S., Greene, T., Boucher, R., et al. (2018) Intensive Systolic Blood Pressure Control and Incident Chronic Kidney Disease in People with and without Diabetes Mellitus: Secondary Analyses of Two Randomised Controlled Trials. The Lancet Diabetes & En-docrinology, 6, 555-563. https://doi.org/10.1016/S2213-8587(18)30099-8
|
[33]
|
De Cosmo, S., Viazzi, F., Piscitelli, P., et al. (2016) Blood Pressure Status and the Incidence of Diabetic Kidney Disease in Patients with Hypertension and Type 2 Diabetes. Journal of Hypertension, 34, 2090-2098.
https://doi.org/10.1097/HJH.0000000000001045
|
[34]
|
Xu, J., Xue, Y., Chen, Q., et al. (2022) Identifying Distinct Risk Thresholds of Glycated Hemoglobin and Systolic Blood Pressure for Rapid Albuminuria Progression in Type 2 Diabetes from Nhanes (1999-2018). Frontiers in Medicine, 9, Article ID: 928825. https://doi.org/10.3389/fmed.2022.928825
|
[35]
|
Russo, G., Piscitelli, P., Giandalia, A., et al. (2020) Atherogenic Dyslipidemia and Diabetic Nephropathy. Journal of Nephrology, 33, 1001-1008. https://doi.org/10.1007/s40620-020-00739-8
|
[36]
|
Roumeliotis, S., Georgianos, P.I., Roumeliotis, A., et al. (2021) Oxidized Ldl Modifies the Association between Proteinuria and Deterioration of Kidney Function in Proteinuric Diabetic Kidney Disease. Life, 11, Article No. 504.
https://doi.org/10.3390/life11060504
|
[37]
|
Lu, C.F., Liu, W.S., Chen, Z.H., et al. (2022) Comparisons of the Rela-tionships between Multiple Lipid Indices and Diabetic Kidney Disease in Patients with Type 2 Diabetes: A Cross-Sectional Study. Frontiers in Endocrinology, 13, Article ID: 888599. https://doi.org/10.3389/fendo.2022.888599
|
[38]
|
Lee, T.S., Lu, T.M., Chen, C.H., et al. (2021) Hyperuricemia In-duces Endothelial Dysfunction and Accelerates Atherosclerosis by Disturbing the Asymmetric Dimethylarg-inine/Dimethylarginine Dimethylaminotransferase 2 Pathway. Redox Biology, 46, Article ID: 102108. https://doi.org/10.1016/j.redox.2021.102108
|
[39]
|
Bartakova, V., Kuricova, K., Pacal, L., et al. (2016) Hyperurice-mia Contributes to the Faster Progression of Diabetic Kidney Disease in Type 2 Diabetes Mellitus. Journal of Diabetes and Its Complications, 30, 1300-1307.
https://doi.org/10.1016/j.jdiacomp.2016.06.002
|
[40]
|
Lai, Y.J., Chen, Y.Y., Ku, P.W., et al. (2021) Association between Uric Acid Level and Incidence of Albuminuria in Patients with Type 2 Diabetes Mellitus: A 4.5-Year Cohort Study. Medicine, 100, e27496.
https://doi.org/10.1097/MD.0000000000027496
|
[41]
|
Bjornstad, P., Laffel, L., Lynch, J., et al. (2019) Elevated Serum Uric Acid Is Associated with Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents with Type 2 Diabetes: An Observational Analysis from the Treatment Options for Type 2 Diabetes in Adolescents and Youth (Today) Study. Diabetes Care, 42, 1120-1128.
https://doi.org/10.2337/dc18-2147
|
[42]
|
Hayashino, Y., Okamura, S., Tsujii, S., et al. (2016) Association of Serum Uric Acid Levels with the Risk of Development Or Progression of Albuminuria among Japanese Patients with Type 2 Diabetes: A Prospective Cohort Study [Diabetes Distress and Care Registry At Tenri (Ddcrt 10)]. Acta Diabetologica, 53, 599-607.
https://doi.org/10.1007/s00592-015-0825-x
|
[43]
|
The GBD 2015 Obesity Collaborators (2017) Health Effects of Overweight and Obesity in 195 Countries Over 25 Years. New England Journal of Medicine, 377, 13-27. https://doi.org/10.1056/NEJMoa1614362
|
[44]
|
龙洁儿, 刘振杰, 丁美祝, 等. 肥胖与糖尿病肾病相关性研究的Meta分析[J]. 中国中西医结合肾病杂志, 2021, 22(1): 29-33.
|
[45]
|
Wang, Y., Chen, F., Wang, J., et al. (2019) The Relationship between Increased Ratio of Visceral-to-Subcutaneous Fat Area and Renal Outcome in Chinese Adults with Type 2 Diabetes and Diabetic Kidney Disease. Canadian Journal of Diabetes, 43, 415-420. https://doi.org/10.1016/j.jcjd.2018.08.199
|
[46]
|
Yang, J.J., Yu, D., Wen, W., et al. (2019) Tobacco Smoking and Mortality in Asia: A Pooled Meta-Analysis. JAMA Network Open, 2, e191474. https://doi.org/10.1001/jamanetworkopen.2019.1474
|
[47]
|
Jiang, S., Quan, D.V., Sung, J.H., et al. (2019) Cigarette Smoke Inhalation Aggravates Diabetic Kidney Injury in Rats. Toxicology Research, 8, 964-971. https://doi.org/10.1039/c9tx00201d
|
[48]
|
Obert, D.M., Hua, P., Pilkerton, M.E., et al. (2011) Environmental To-bacco Smoke Furthers Progression of Diabetic Nephropathy. The American Journal of the Medical Sciences, 341, 126-130.
https://doi.org/10.1097/MAJ.0b013e3181f6e3bf
|
[49]
|
Feodoroff, M., Harjutsalo, V., Forsblom, C., et al. (2015) Smoking and Progression of Diabetic Nephropathy in Patients with Type 1 Diabetes. Acta Diabetologica, 53, 525-533. https://doi.org/10.1007/s00592-015-0822-0
|
[50]
|
Öberg, M., Jaakkola, M.S., Woodward, A., et al. (2011) World-wide Burden of Disease from Exposure to Second-Hand Smoke: A Retrospective Analysis of Data from 192 Countries. The Lancet, 377, 139-146.
https://doi.org/10.1016/S0140-6736(10)61388-8
|
[51]
|
Jhee, J.H., Joo, Y.S., Kee, Y.K., et al. (2019) Secondhand Smoke and CKD. Clinical Journal of the American Society of Nephrology, 14, 515-522. https://doi.org/10.2215/CJN.09540818
|
[52]
|
Braffett, B.H., Rice, M.M., Young, H.A., et al. (2019) Mediation of the Association of Smoking and Microvascular Complications by Glycemic Control in Type 1 Diabetes. PLOS ONE, 14, e0210367.
https://doi.org/10.1371/journal.pone.0210367
|
[53]
|
Ito, K., Yokota, S., Watanabe, M., et al. (2021) Anemia in Dia-betic Patients Reflects Severe Tubulointerstitial Injury and Aids in Clinically Predicting a Diagnosis of Diabetic Nephrop-athy. Internal Medicine, 60, 1349-1357.
https://doi.org/10.2169/internalmedicine.5455-20
|
[54]
|
Fujita, Y., Doi, Y., Hamano, T., et al. (2019) Low Erythro-poietin Levels Predict Faster Renal Function Decline in Diabetic Patients with Anemia: A Prospective Cohort Study. Sci-entific Reports, 9, Article No. 14871.
https://doi.org/10.1038/s41598-019-51207-8
|
[55]
|
Eren, Z., Gunal, M.Y., Ari, E., et al. (2016) Pleiotropic and Renoprotective Effects of Erythropoietin Beta on Experimental Diabetic Nephropathy Model. Nephron, 132, 292-300. https://doi.org/10.1159/000444649
|
[56]
|
王晓红, 左淑丽. 血清25羟基维生素D水平与糖尿病微血管病变的关系及临床意义[J]. 中国综合临床, 2020, 36(6): 496-500.
|
[57]
|
Wang, Y., Yang, S., Zhou, Q., et al. (2019) Effects of Vitamin D Supplementation on Renal Function, Inflammation and Glycemic Control in Patients with Diabetic Nephropa-thy: A Systematic Review and Meta-Analysis. Kidney and Blood Pressure Research, 44, 72-87. https://doi.org/10.1159/000498838
|